| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
6e-11 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-08 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.31 |
1e-08 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |